NASDAQ:ZGNX
Delisted
Zogenix Stock News
$26.68
+0 (+0%)
At Close: Jul 20, 2022
Zogenix Reports Granting of Inducement Awards
05:39pm, Thursday, 16'th Sep 2021
EMERYVILLE, Calif., Sept. 16, 2021 (GLOBE NEWSWIRE) -- Zogenix (NASDAQ: ZGNX) today announced that the compensation committee of the company's board of directors granted inducement awards to fourteen
3 Biotech Stocks Wall Street Expects to Double Soon
07:03am, Tuesday, 07'th Sep 2021
All three stocks on this list can more than double your money according to investment bank analysts who cover them.
3 Hypergrowth Stocks Expected to Increase Sales 1,185% to 12,629% by 2023
06:06am, Friday, 03'rd Sep 2021
These fast-paced companies should generate jaw-dropping revenue growth over the next three years.
Zogenix Reports Granting of Inducement Awards
05:02pm, Monday, 16'th Aug 2021
EMERYVILLE, Calif., Aug. 16, 2021 (GLOBE NEWSWIRE) -- Zogenix (NASDAQ: ZGNX) today announced that the compensation committee of the company's board of directors granted inducement awards to fourteen
4 Stocks Insiders Are Buying
08:10am, Friday, 13'th Aug 2021
When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock.
Zogenix, Inc. (ZGNX) CEO Dr. Stephen Farr on Q2 2021 Results - Earnings Call Transcript
05:28pm, Friday, 06'th Aug 2021
Zogenix, Inc. (ZGNX) CEO Dr. Stephen Farr on Q2 2021 Results - Earnings Call Transcript
Recap: Zogenix Q2 Earnings
05:25pm, Thursday, 05'th Aug 2021
Shares of Zogenix (NASDAQ:ZGNX) rose in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share decreased 9.38% year over year to ($1.05), which missed the est
Zogenix to Participate in the BofA Securities SMID Cap 2H21 Ideas Conference
04:05pm, Tuesday, 03'rd Aug 2021
EMERYVILLE, Calif., Aug. 03, 2021 (GLOBE NEWSWIRE) -- Zogenix (NASDAQ: ZGNX), a global biopharmaceutical company developing and commercializing rare disease therapies, today announced that Stephen
2021 Top Idea Contest - New Ideas
11:53am, Thursday, 29'th Jul 2021
Today, we have our "Double Down or Diversify" series. We have 13 new ideas that contributors have chosen for the second half of the contest.
Zogenix: Await Q2 Fintepla Revenue, LGS Approval Before Jumping Back In
07:29am, Wednesday, 21'st Jul 2021
Zogenix: Await Q2 Fintepla Revenue, LGS Approval Before Jumping Back In
EMERYVILLE, Calif., July 14, 2021 (GLOBE NEWSWIRE) -- Zogenix, a global biopharmaceutical company developing rare disease therapies, and ten U.S. advocacy groups today announced the launch of VIP S
Zogenix's Current Price Seems Disconnected From A Strong Fintepla Launch
11:44am, Wednesday, 23'rd Jun 2021
Zogenix's Current Price Seems Disconnected From A Strong Fintepla Launch
Zogenix to Participate in Two Upcoming Investor Conferences
08:00am, Monday, 21'st Jun 2021
EMERYVILLE, Calif., June 21, 2021 (GLOBE NEWSWIRE) -- Zogenix (NASDAQ: ZGNX), a global biopharmaceutical company developing and commercializing rare disease therapies, today announced that members of
Zogenix to Participate in the BofA Securities 2021 Healthcare Conference
04:01pm, Tuesday, 11'th May 2021
EMERYVILLE, Calif., May 11, 2021 (GLOBE NEWSWIRE) -- Zogenix (NASDAQ: ZGNX), a global biopharmaceutical company developing and commercializing rare disease therapies, today announced that Stephen J.
Zogenix, Inc. (ZGNX) CEO Stephen Farr on Q1 2021 Results - Earnings Call Transcript
10:58pm, Thursday, 06'th May 2021
Zogenix, Inc. (ZGNX) CEO Stephen Farr on Q1 2021 Results - Earnings Call Transcript
